Fetotoxic alterations in the normal ontogenies of rat microsomal and lysosomal enzymes.
The activity patterns during development for acid phosphatase (Ac-P), alkaline phosphatase (A1-P), beta-glucuronidase (beta G), and UDP-glucuronyltransferase (UDPGT) have been determined in various tissues of the rat for corn oil and distilled water controls as well as in animals prenatally exposed to four fetotoxic chemicals. Postnatal assays were performed on both sexes separately. In control animals, tissue-specific differences between male and female activity levels were found for UDPGT. In the liver of mature offspring, enzyme activity was greater in males than in females. Although no sex difference was observed in the intestine, the kidneys of females exhibited higher values than those of males. An original computer-assisted methodology is presented, designed (a) to permit a mathematical description for the complex curves exhibited by these ontogeny profiles, and (b) to assess the statistical significance of chemical-induced alterations in these complex developmental patterns, specifically, to target sensitive periods and subtle changes near the fetotoxic threshold. Oral administration (days 6-18 of gestation) of 3,3',4,4'-tetrachlorobiphenyl (4CB) to pregnant females resulted in an induction of liver UDPGT activity in offspring postnatally, and some alterations in the perinatal pattern of beta G in the same tissue. This treatment also produced differences in the intestinal patterns of Ac-P and male UDPGT. No significant changes were observed in offspring exposed to diethylstilbestrol (DES). Treatment with zeranol (ZN) caused reductions in activity over the entire postnatal period for beta G in liver, brain, intestine, and kidney, for A1-P in brain, and for Ac-P in the intestine. Cadmium-treated dams gave birth to offspring that exhibited slightly altered ontogenies only in intestine for UDPGT and AcP. The alterations in these developmental profiles indicate periods of increased sensitivity, and may be useful in directing more specific studies into the fetotoxic mechanisms of these compounds.
Harris
C
C
Department of Zoology, Brigham Young University, Provo, Utah 84602.
Thomas
D E
DE
Carter
M W
MW
Bradshaw
W S
WS
D000135:Acid Phosphatase / Q000378:metabolism*; D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000378:metabolism*; D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000201:enzymology; D005966:Glucuronidase / Q000378:metabolism*; D014453:Glucuronosyltransferase / Q000378:metabolism*; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D008431:Maternal-Fetal Exchange; D008861:Microsomes / Q000201:enzymology; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D013723:Teratogens / Q000494:pharmacology*
D013723:Teratogens; D014453:Glucuronosyltransferase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D005966:Glucuronidase